Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor‐Tezacaftor‐Ivacaftor Therapy

Documenti analoghi

• Impact of Elexacaftor‐Tezacaftor‐Ivacaftor on Quality of Life in Children With Cystic Fibrosis
  di: Sara Kümmerli, et al.
  Pubblicazione: (2026)
• Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis
  di: Burcu Uzunoglu, et al.
  Pubblicazione: (2025)
• Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
  di: Cindy L. Williams, et al.
  Pubblicazione: (2025)
• Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase‐1 in Children With Cystic Fibrosis
  di: Senthilkumar Sankararaman, et al.
  Pubblicazione: (2025)
• Effects of Elexacaftor‐Tezacaftor‐Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis
  di: Guillaume Petit, et al.
  Pubblicazione: (2025)